The cost of marginal medicine is too high.
作者信息
Emanuel Ezekiel J
出版信息
MedGenMed. 2005 Dec 12;7(4):67.
Abstract
摘要
相似文献
1
The cost of marginal medicine is too high.边缘医学的成本过高。
MedGenMed. 2005 Dec 12;7(4):67.
2
Expert urges doctors to test ACO model.专家敦促医生测试负责医疗组织模式。
Minn Med. 2010 Nov;93(11):20-1.
3
Value-based health care delivery.基于价值的医疗服务提供。
Ann Surg. 2008 Oct;248(4):503-9. doi: 10.1097/SLA.0b013e31818a43af.
4
We can have it all. ACOs can be driving force in health systems delivering quality care, low costs.我们可以兼得。负责医疗组织可以成为医疗系统中提供优质护理、低成本服务的驱动力。
Mod Healthc. 2011 May 23;41(21):20.
5
A commitment to value, unleashed: hospitals step up.释放对价值的承诺：医院挺身而出。
Hosp Health Netw. 2013 May;87(5):59.
6
The price for probability: Comparing the costs of diagnostic testing strategies.
J Nucl Cardiol. 2007 Apr;14(2):142-4. doi: 10.1016/j.nuclcard.2007.01.038.
7
8
Practices must identify the cost of care to succeed in an era of accountability.在问责制时代，医疗机构必须明确医疗成本才能取得成功。
MGMA Connex. 2012 Jan;12(1):34-5.
9
Commentary: balancing quality and cost in the health care market.评论：平衡医疗保健市场中的质量与成本
Am J Med Qual. 1995 Fall;10(3):155-6. doi: 10.1177/0885713X9501000308.
10
Professionalism, accountability and peer review.
Health Serv Res. 1982 Summer;17(2):113-23.
引用本文的文献
1
Assessing the clinical benefit from medical therapies in CNS malignancies: Refining the ESMO Magnitude of Clinical Benefit Scale and the ASCO Value Framework.评估中枢神经系统恶性肿瘤医学治疗的临床获益：完善欧洲肿瘤内科学会临床获益程度量表和美国临床肿瘤学会价值框架。
Neurooncol Adv. 2025 Jun 20;7(1):vdaf127. doi: 10.1093/noajnl/vdaf127. eCollection 2025 Jan-Dec.
2
Between January 2009 and April 2016, 134 novel anticancer therapies were approved: what is the level of knowledge concerning the clinical benefit at the time of approval?2009年1月至2016年4月期间，有134种新型抗癌疗法获批：获批时对其临床获益的了解程度如何？
ESMO Open. 2017 Jan 31;1(6):e000125. doi: 10.1136/esmoopen-2016-000125. eCollection 2016.
本文引用的文献
1
Health care expenditures reexamined.重新审视医疗保健支出。
Ann Intern Med. 2005 Jul 5;143(1):76-8. doi: 10.7326/0003-4819-143-1-200507050-00012.
2
High and rising health care costs. Part 3: the role of health care providers.高昂且不断上涨的医疗保健成本。第3部分：医疗保健提供者的作用。
Ann Intern Med. 2005 Jun 21;142(12 Pt 1):996-1002. doi: 10.7326/0003-4819-142-12_part_1-200506210-00009.
3
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.西妥昔单抗单药治疗及西妥昔单抗联合伊立替康治疗伊立替康难治性转移性结直肠癌。
N Engl J Med. 2004 Jul 22;351(4):337-45. doi: 10.1056/NEJMoa033025.
4
The price tag on progress--chemotherapy for colorectal cancer.进步的代价——结直肠癌的化疗
N Engl J Med. 2004 Jul 22;351(4):317-9. doi: 10.1056/NEJMp048143.
5
Shattuck Lecture--cutting cost without cutting the quality of care.沙塔克讲座——在不降低医疗质量的前提下削减成本。
N Engl J Med. 1978 Jun 1;298(22):1229-38. doi: 10.1056/NEJM197806012982204.
Zotero 插件